As of 11:30 AM on the 4th, Ilyang Pharmaceutical's stock price is 50,600 KRW, up 1.2% from the previous day, with a trading volume of 612,403 shares, which is 12.49% of the 5-day average trading volume. On May 29, Ilyang Pharmaceutical became a market issue with the news of 'COVID-19 treatment clinical trial approval causing consecutive surges.'
In addition to Ilyang Pharmaceutical, posts by investors are also rapidly increasing for Dreamtech (192650), SK (034730), and Hyundai Steel (004020).

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
